Drug Database
Back to search

Belgium· BE-AMP-SAM094857-00

Lanitop 0.1 mg

A metildigoxin product containing metildigoxin, registered in Belgium by Esteve Pharmaceuticals. The same ATC class is registered in 3 of our 19 countries.

ATC C01AA08

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedLanitop 0.1 mgATCC01AA08REGISTER NO.BE-AMP-SAM094857-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about metildigoxinAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Metildigoxin is registered in 3 of 19 countries.

Countries holding a registration under ATC C01AA08 (metildigoxin), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 1 of them publish a price we can compare per daily dose
Search metildigoxin products by name

Metildigoxin · ATC C01AA08

3 / 19 countries

  • Belgiumprice
  • Germany
  • Japan
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Metildigoxin
Manufacturer
Esteve Pharmaceuticals
Country
Belgium (BE)
ATC code
C01AA08
ATC class
Metildigoxin
Defined daily dose
0.2 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

1 priced
  • be_apb
    0118703
    EUR 7.49
  • be_apb
    0710244

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Metildigoxin in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All metildigoxin products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Austria · Lanitop®
  • Bulgaria · Ланитоп
  • Germany · Lanitop
  • Spain · Lanirapid
  • Croatia · Lanitop
  • Portugal · Lanitop
  • Slovenia · Lanitop

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a33d671e-b5e9-435f-8bfd-ba437f8cd5b3
GET /v1/drugs/a33d671e-b5e9-435f-8bfd-ba437f8cd5b3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Lanitop 0.1 mg",
  "name_fr": "Lanitop 0.1 mg",
  "name_nl": "Lanitop 0.1 mg",
  "amp_code": "SAM094857-00",
  "strengths": [
    "0.1000",
    "60.6000",
    "3.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Metildigoxin",
    "Lactose Monohydrate",
    "Sodium Starch Glycolate (Type A)"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Metildigoxin",
  "authorisation_numbers": [
    "BE094857"
  ]
}
API referenceMCP serverPlans

See everything about metildigoxin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console